VALIANT LABORATORIES
|
VALIANT LABORATORIES Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
Profit Before Tax | ₹-0.77 Cr | ₹38 Cr |
Adjustment | ₹2.04 Cr | ₹1.56 Cr |
Changes In working Capital | ₹-0.37 Cr | ₹25 Cr |
Cash Flow after changes in Working Capital | ₹0.90 Cr | ₹65 Cr |
Cash Flow from Operating Activities | ₹1.89 Cr | ₹56 Cr |
Cash Flow from Investing Activities | ₹-144 Cr | ₹-55 Cr |
Cash Flow from Financing Activities | ₹152 Cr | ₹-0.93 Cr |
Net Cash Inflow / Outflow | ₹10 Cr | ₹-0.05 Cr |
Opening Cash & Cash Equivalents | ₹1.26 Cr | ₹1.31 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
Effect of Foreign Exchange Fluctuations | - | - |
Closing Cash & Cash Equivalent | ₹12 Cr | ₹1.26 Cr |
Compare Cashflow Statement of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹485.2 Cr | -3.7% | 4.2% | -20% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,017.0 Cr | -0.2% | -0.5% | 10.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,867.0 Cr | 4% | 4.8% | 50.5% | Stock Analytics | |
CIPLA | ₹122,451.0 Cr | 0.4% | 3.1% | 1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,620.0 Cr | 5.9% | 9.1% | 23% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,572.0 Cr | -4.8% | 2.2% | 2.9% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -3.7% |
4.2% |
-20% |
SENSEX | 2% |
2.8% |
6.4% |
You may also like the below Video Courses